Vice President, Global Environmental Health & Safety
Revolution Medicines
Summary
The Vice President, Global Environmental Health & Safety (EHS) is RevMed’s senior enterprise leader accountable for defining and executing the company’s global EHS strategy. This executive will establish the governance, operating model, talent, and management systems required to protect employees, patients, communities, and business continuity across a growing global pharmaceutical enterprise.
Job description
The Opportunity
The Vice President, Global Environmental Health & Safety (EHS) is RevMed’s senior enterprise leader accountable for defining and executing the company’s global EHS strategy. This executive will establish the governance, operating model, talent, and management systems required to protect employees, patients, communities, and business continuity across a growing global pharmaceutical enterprise.
Key Responsibilities
- Define the enterprise EHS vision, multi-year roadmap, policies, standards, and operating model for a global pharmaceutical company.
- Lead EHS due diligence for new offices and facilities worldwide; establish repeatable global playbooks.
- Develop scalable EHS programs for a worldwide workforce, including field sales, medical affairs, market access, remote and hybrid employees.
- Integrate EHS risk into enterprise risk management, business planning, capital allocation, business continuity, crisis management, insurance, and executive decision-making.
- Maintain a risk-based global compliance framework addressing occupational safety, environmental protection, fire and life safety, hazardous materials and waste, biosafety, transportation, contractor safety, and occupational health.
- Serve as the principal EHS advisor to executive leadership and the Board on material risks, emerging regulatory trends, performance, crisis response, and investment priorities.
- Build, lead, and develop a high-performing global EHS organization and regional network.
- Establish enterprise metrics, dashboards, management reviews, audit protocols, corrective-action governance, and executive reporting.
- Ensure timely escalation, investigation, root-cause analysis, corrective action, and organizational learning for incidents and near misses worldwide.
- Provide strategic oversight for laboratory, office, and technical-operations safety programs.
- Own the integrity and governance of EHS- and sustainability-related ESG data, including definitions, methodologies, internal controls, source documentation, validation, and executive certification.
- Develop a risk-based roadmap for greenhouse-gas emissions, energy, water, waste, hazardous materials, climate resilience, and responsible resource use.
Required Skills, Experience and Education
- BS/BA degree in Environmental Health & Safety, industrial hygiene, occupational safety, environmental science, engineering, life sciences, or a related discipline; an advanced degree is preferred.
- At least 18 years of progressively responsible EHS experience, including significant executive-level leadership in the global pharmaceutical industry.
- Demonstrated experience leading EHS for a multinational pharmaceutical company with operations across multiple countries and regions.
- Experience must include direct accountability for global strategy, governance, regulatory compliance, audit and assurance, incident management, and executive reporting.
- At least 10 years of people-leadership experience, with demonstrated success building, scaling, and leading global or regional EHS teams across a complex, matrixed organization.
- Demonstrated experience supporting a broad pharmaceutical operating model, including research laboratories, clinical development, technical operations, external manufacturing, supply chain, corporate offices, and commercial or medical field organizations.
- Demonstrated experience opening and integrating international offices or facilities, establishing EHS programs in new countries, and translating enterprise standards into locally compliant requirements.
- Demonstrated experience managing EHS for a worldwide, mobile, and field-based workforce, including global sales, medical affairs, market access, or comparable commercial organizations.
- Deep knowledge of U.S. EHS requirements, including OSHA, EPA, and Cal/OSHA, together with a strong working knowledge of international EHS regulatory frameworks.
- Demonstrated leadership of ESG or corporate sustainability programs within a global pharmaceutical or similarly regulated life-sciences company.
- Executive presence and the ability to communicate complex risk, regulatory, and operational issues clearly to the Board, senior executives, employees, regulators, investors, and external partners.
- Strong business judgment, change-management capability, and demonstrated success prioritizing risk and investment in a fast-paced, high-growth, science-driven organization.
- Ability and willingness to travel domestically and internationally.
Preferred Skills
- MA/MS, MBA, or other relevant advanced degree.
- Professional certification such as CSP, CIH, CHMM, or equivalent international credential.
- Experience implementing and sustaining global EHS management systems aligned with recognized standards such as ISO 45001 and ISO 14001.
- Experience engaging with global regulators, works councils, occupational-health providers, insurers, and external assurance partners.
- Working knowledge of leading ESG and sustainability frameworks and disclosure regimes relevant to multinational companies.
- Experience developing greenhouse-gas inventories and reduction roadmaps, evaluating Scope 3 emissions, engaging suppliers and external manufacturing partners, and preparing ESG information for third-party assurance, investor review, or public reporting.
- Multilingual capability is a plus.
Requirements
- BS/BA degree in Environmental Health & Safety, industrial hygiene, occupational safety, environmental science, engineering, life sciences, or a related discipline; an advanced degree is preferred.
- At least 18 years of progressively responsible EHS experience, including significant executive-level leadership in the global pharmaceutical industry.
- Demonstrated experience leading EHS for a multinational pharmaceutical company with operations across multiple countries and regions.
- Experience must include direct accountability for global strategy, governance, regulatory compliance, audit and assurance, incident management, and executive reporting.
- At least 10 years of people-leadership experience, with demonstrated success building, scaling, and leading global or regional EHS teams across a complex, matrixed organization.
- Demonstrated experience supporting a broad pharmaceutical operating model, including research laboratories, clinical development, technical operations, external manufacturing, supply chain, corporate offices, and commercial or medical field organizations.
- Demonstrated experience opening and integrating international offices or facilities, establishing EHS programs in new countries, and translating enterprise standards into locally compliant requirements.
- Demonstrated experience managing EHS for a worldwide, mobile, and field-based workforce, including global sales, medical affairs, market access, or comparable commercial organizations.
- Deep knowledge of U.S. EHS requirements, including OSHA, EPA, and Cal/OSHA, together with a strong working knowledge of international EHS regulatory frameworks and the ability to govern compliance through regional leaders and local subject-matter experts.
- Demonstrated leadership of ESG or corporate sustainability programs within a global pharmaceutical or similarly regulated life-sciences company, including strategy development, governance, metrics, target setting, disclosure, data controls, and executive or Board reporting.
- Executive presence and the ability to communicate complex risk, regulatory, and operational issues clearly to the Board, senior executives, employees, regulators, investors, and external partners.
- Strong business judgment, change-management capability, and demonstrated success prioritizing risk and investment in a fast-paced, high-growth, science-driven organization.
- Ability and willingness to travel domestically and internationally.
Benefits
- Competitive cash compensation
- Equity awards
- Health benefits
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.